ArticleEClinicalMedicine2024

Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): five-year outcomes of a randomised trial.

Neil Marlow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.